alexa Management of rheumatic disease with comorbid HBV or HCV infection.


Journal of Clinical & Cellular Immunology

Author(s): Vassilopoulos D, Calabrese LH

Abstract Share this page

Abstract Despite the major advances towards better prevention and treatment of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections, these two chronic infections still account for ∼500 million infected people and 1 million deaths per year worldwide. Rheumatologists are frequently encountering patients with rheumatic disease who have co-existing HBV or HCV infection in daily clinical practice. Moreover, over the past decade, a number of studies have shown an increased risk of HBV reactivation and liver-related complications in HBV-infected patients treated with biologic agents (especially anti-TNF therapies). In this Review, the basic viral characteristics of HBV and HCV, as well as the natural course of chronic HBV and HCV infection, are outlined. Furthermore, a rational clinical approach for diagnosis and treatment of these comorbid conditions in the context of rheumatic disease is presented. This article was published in Nat Rev Rheumatol and referenced in Journal of Clinical & Cellular Immunology

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version